Biotechnology CRISPR Therapeutics to Present at the 2022 BMO Growth & ESG Conference December 1, 2022
Biotechnology Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using Circulating Tumor DNA (ctDNA) December 1, 2022
Biotechnology Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market December 1, 2022
Biotechnology Alkermes to Participate in the BofA Securities 2022 Biotech SMID Cap Conference November 30, 2022
Search
Biotechnology
